Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus XR vs Prograf in Liver Transplantation
NCT03828058Phase 2Completed
- Sponsor
- Methodist Healthcare System of San Antonio
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in Liver transplant rejection, sponsored by Methodist Healthcare System of San Antonio. Started Apr 2019; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT03828058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03828058.